Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Public Health Manag Pract ; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years: S77-S83, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31348193

RESUMEN

Documenting Tribal health priorities is needed to inform research agendas, policy efforts, advocacy, and funding. However, published literature rarely documents the methods used to develop surveys in Indigenous communities. This methods paper includes two objectives: (1) increase knowledge and understanding about the importance of community involvement in public health activities; and (2) provide an example of how the Rocky Mountain Tribal Leaders Council Epidemiology Center (RMTEC) worked with one Tribal community to develop a health priorities survey. This paper describes how the RMTEC worked with a Tribal community and Tribal College students to develop, pilot, and revise a health priorities survey. Recommendations focus on the need for more culturally-responsive survey methods, the importance of building Tribal capacity for health research, and the value of piloting surveys in communities prior to implementation.


Asunto(s)
Participación de la Comunidad/métodos , Encuestas y Cuestionarios/normas , Participación de la Comunidad/estadística & datos numéricos , Humanos , Proyectos Piloto , Encuestas y Cuestionarios/estadística & datos numéricos
2.
Clin Lymphoma Myeloma Leuk ; 24(1): 32-39, 2024 01.
Artículo en Inglés | MEDLINE | ID: mdl-37783639

RESUMEN

Black and Latino/Hispanic populations are disproportionately impacted by multiple myeloma (MM) in the United States and are underrepresented in many clinical trials. The Multiple Myeloma Research Foundation sponsored a 1-day workshop of 46 experts spanning the ecosystem of MM research and care, including government, academia, nonprofits, pharma/biotech, community partners, and retail pharmacy. Specific, tangible steps to overcome the well-documented barriers to improving the diversity and inclusivity of clinical trials were discussed, including broadening inclusion/exclusion criteria, reducing the financial and other burdens of trial participants, selecting diverse study sites, including implicit bias training, and taking steps to empower patients.


Asunto(s)
Ensayos Clínicos como Asunto , Mieloma Múltiple , Humanos , Hispánicos o Latinos , Mieloma Múltiple/terapia , Negro o Afroamericano , Selección de Paciente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA